Guest Editors
Dr. Awais Ullah Ihsan
E-mail: Awais.Ullah.Ihsan@usherbrooke.ca
Affiliation: Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, QC, J1K 2R1, Canada.
Homepage:
Research Interests: Cancer, Molecular therapy, Gene Therapy, Tumor suppressor, Inflammation, Molecular Biology, Animal models
Summary
Prostate cancer has emerged as one of the most common malignancies worldwide requiring innovative therapeutic strategies in improving patient outcomes. Recently, molecular therapeutics have changed the treatment scenario significantly and opened up new dimensions of precision medicine and targeted therapies based on gene intervention. With this overview, this special issue aims to highlight the latest developments regarding molecular therapeutics for prostate cancer that could translate into clinical practice, with the promise of improving efficacy and reducing treatment toxicity.
Key focus areas include next-generation molecular targets and tumor suppressor pathways in therapeutic interventions. Topics will also cover cutting-edge approaches such as RNA-based therapies, and gene editing technologies, and their implications for personalized treatment. In addition, this issue would address predictive biomarkers for the choice of therapy and resistance management - all of which are valuable for patient stratification and treatment success.
In this way, this special issue will not only provide a broader platform for comprehensive reviews, cutting-edge original research, and expert approaches but also significantly expand the field of molecular therapeutics for prostate cancer. Ultimately, it aims to contribute through collaboration and innovation toward better clinical outcomes and quality of life for patients.
Keywords
Molecular therapeutics, prostate cancer, precision medicine, targeted therapies, gene therapy, RNA-based therapeutics, tumor suppressors, predictive biomarkers, resistance management, personalized treatment
Login
Register
Submit a Paper
Propose a Special lssue